CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a japanese population

Tomomitsu Tahara, Tomoyuki Shibata, Ichiro Hirata, Hiroshi Nakano, Tomiyasu Arisawa

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a japanese population'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology